What are the key differences between fully human monoclonal antibodies and humanized monoclonal antibodies in terms of their effectiveness and potential applications in medical treatments?

Fully human monoclonal antibodies are derived entirely from human sources, making them less likely to cause immune reactions. They are generally more effective and have a lower risk of side effects compared to humanized monoclonal antibodies, which contain some non-human components. Fully human monoclonal antibodies are often preferred for medical treatments due to their higher specificity and reduced risk of adverse reactions.